Aspatwar A, Becker HM, Parvathaneni NK, Hammaren M, Svorjova A, Barker H, Supuran CT, Dubois L, Lambin P, Parikka M, Parkkila S, Winum JY
Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytes.
J Enzyme Inhib Med Chem
;33(1)1064-1073, 2018
PMID
Aspatwar A, Winum JY, Carta F, Supuran CT, Hammaren M, Parikka M, Parkkila S
In Vivo Studies.
Molecules ;2018
PMIDLuukinen H, Hammarén MM, Vanha-Aho LM, Parikka M
Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish.
J Vis Exp ;2018
PMIDMyllymäki H, Niskanen M, Luukinen H, Parikka M, Rämet M
Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish.
Dis Model Mech ;2018
PMIDLuukinen H, Hammarén MM, Vanha-Aho LM, Svorjova A, Kantanen L, Järvinen S, Luukinen BV, Dufour E, Rämet M, Hytönen VP, Parikka M
Listeria monocytogenes induces sterilizing response in the adult zebrafish tuberculosis model.
Dis Model Mech ;2018
Aspatwar A, Hammarén M, Koskinen S, Luukinen B, Barker H, Carta F, Supuran CT, Parikka M, Parkkila S
β-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis.
J Enzyme Inhib Med Chem
;32(1)832-840, 2017
PMID
Myllymäki H, Niskanen M, Oksanen KE, Sherwood E, Ahava M, Parikka M, Rämet M
Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio).
PLoS One
;12(7)e0181942, 2017
PMIDBootorabi F, Manouchehri H, Changizi R, Barker H, Palazzo E, Saltari A, Parikka M, Pincelli C, Aspatwar A
Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer.
Int J Mol Sci ;2017
PMIDAl-Samadi A, Awad SA, Tuomainen K, Zhao Y, Salem A, Parikka M, Salo T
in vivo models.
Oncotarget
;8(36)60123-60134, 2017
PMIDOksanen KE, Myllymäki H, Ahava MJ, Mäkinen L, Parikka M, Rämet M
DNA vaccination boosts Bacillus Calmette-Guérin protection against mycobacterial infection in zebrafish.
Dev Comp Immunol
;54(1)89-96, 2016
PMIDAspatwar A, Tolvanen ME, Ojanen MJ, Barker HR, Saralahti AK, Bäuerlein CA, Ortutay C, Pan P, Kuuslahti M, Parikka M, Rämet M, Parkkila S
Inactivation of ca10a and ca10b Genes Leads to Abnormal Embryonic Development and Alters Movement Pattern in Zebrafish.
PLoS One
;10(7)e0134263, 2015
PMIDOjanen MJ, Turpeinen H, Cordova ZM, Hammarén MM, Harjula SK, Parikka M, Rämet M, Pesu M
The proprotein convertase subtilisin/kexin furinA regulates zebrafish host response against Mycobacterium marinum.
Infect Immun
;83(4)1431-42, 2015
PMIDHammarén MM, Oksanen KE, Nisula HM, Luukinen BV, Pesu M, Rämet M, Parikka M
Adequate Th2-type response associates with restricted bacterial growth in latent mycobacterial infection of zebrafish.
PLoS Pathog
;10(6)e1004190, 2014
PMIDSaralahti A, Piippo H, Parikka M, Henriques-Normark B, Rämet M, Rounioja S
Adult zebrafish model for pneumococcal pathogenesis.
Dev Comp Immunol
;42(2)345-53, 2014
PMIDTurpeinen H, Oksanen A, Kivinen V, Kukkurainen S, Uusimäki A, Rämet M, Parikka M, Hytönen VP, Nykter M, Pesu M
Proprotein convertase subtilisin/kexin type 7 (PCSK7) is essential for the zebrafish development and bioavailability of transforming growth factor β1a (TGFβ1a).
J Biol Chem
;288(51)36610-23, 2013
PMIDTaskinen B, Zmurko J, Ojanen M, Kukkurainen S, Parthiban M, Määttä JA, Leppiniemi J, Jänis J, Parikka M, Turpeinen H, Rämet M, Pesu M, Johnson MS, Kulomaa MS, Airenne TT, Hytönen VP
Zebavidin–an avidin-like protein from zebrafish.
PLoS One
;8(10)e77207, 2013
PMIDOksanen KE, Halfpenny NJ, Sherwood E, Harjula SK, Hammarén MM, Ahava MJ, Pajula ET, Lahtinen MJ, Parikka M, Rämet M
An adult zebrafish model for preclinical tuberculosis vaccine development.
Vaccine
;31(45)5202-9, 2013
PMIDAspatwar A, Tolvanen ME, Jokitalo E, Parikka M, Ortutay C, Harjula SK, Rämet M, Vihinen M, Parkkila S
Abnormal cerebellar development and ataxia in CARP VIII morphant zebrafish.
Hum Mol Genet
;22(3)417-32, 2013
PMIDLohi O, Parikka M, Rämet M
The zebrafish as a model for paediatric diseases.
Acta Paediatr
;102(2)104-10, 2013
PMIDMao J, Wang D, Mataleena P, He B, Niu D, Katayama K, Xu X, Ojala JR, Wang W, Shu Q, Du L, Liu A, Pikkarainen T, Patrakka J, Tryggvason K
Myo1e impairment results in actin reorganization, podocyte dysfunction, and proteinuria in zebrafish and cultured podocytes.
PLoS One
;8(8)e72750, 2013
PMIDTeittinen KJ, Grönroos T, Parikka M, Junttila S, Uusimäki A, Laiho A, Korkeamäki H, Kurppa K, Turpeinen H, Pesu M, Gyenesei A, Rämet M, Lohi O
SAP30L (Sin3A-associated protein 30-like) is involved in regulation of cardiac development and hematopoiesis in zebrafish embryos.
J Cell Biochem
;113(12)3843-52, 2012
PMIDPatterson H, Saralahti A, Parikka M, Dramsi S, Trieu-Cuot P, Poyart C, Rounioja S, Rämet M
Adult zebrafish model of bacterial meningitis in Streptococcus agalactiae infection.
Dev Comp Immunol
;38(3)447-55, 2012
PMIDParikka M, Hammarén MM, Harjula SK, Halfpenny NJ, Oksanen KE, Lahtinen MJ, Pajula ET, Iivanainen A, Pesu M, Rämet M
Mycobacterium marinum causes a latent infection that can be reactivated by gamma irradiation in adult zebrafish.
PLoS Pathog
;8(9)e1002944, 2012
PMIDTeittinen KJ, Grönroos T, Parikka M, Rämet M, Lohi O
The zebrafish as a tool in leukemia research.
Leuk Res
;36(9)1082-8, 2012
PMIDRounioja S, Saralahti A, Rantala L, Parikka M, Henriques-Normark B, Silvennoinen O, Rämet M
Defense of zebrafish embryos against Streptococcus pneumoniae infection is dependent on the phagocytic activity of leukocytes.
Dev Comp Immunol
;36(2)342-8, 2012
PMID
Mao J, Wang D, Parikka M, He B, Niu D, Katayama K, Xu X, Ojala JR, Wang W, Shu Q, Du L, Liu A, Pikkarainen T, Patrakka J, Tryggvason K. Myo1e impairment results in actin reorganization, podocyte dysfunction, and proteinuria in zebrafish and cultured podocytes. PLoS One. 2013 Aug 19;8(8):e72750.